2022
Pincez T, Fernandes H, Leblanc T, Michel G, Barlogis V, Bertrand Y, et al. Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden. Haematologica. 2022 (PUBMED – Site de la revue)
Dhunputh C, Ducassou S, Fernandes H, Picard C, Rieux-Laucat F, Viallard J-F, et al. Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects. Blood. 2022 (PUBMED – Site de la revue)
Pincez T, Aladjidi N, Heritier S, Garnier N, Fahd M, Abou Chahla W, et al. Determinants of splenectomy long-term outcomes in pediatric autoimmune cytopenias. Blood. 2022 (PUBMED – Site de la revue)
2021
Ducassou S, Fernandes H, Savel H, Bertrand Y, Leblanc T, Abou Chahla W, et al. Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation. J Pediatr. 2021(PUBMED – Site de la revue)
Nolla M, Aladjidi N, Leblanc TM, Fernandes H, Ducassou S, Fahd M, et al. Thrombopoietin receptor agonists as an emergency treatment of severe newly diagnosed immune thrombocytopenia in children. Blood. 2021. (PUBMED – Site de la revue)
2020
Margot H, Boursier G, Duflos C, Sanchez E, Amiel J, Andrau J-C, et al. Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals. Genet Med Off J Am Coll Med Genet. 2020 (PUBMED – Site de la revue)
Ducassou S, Gourdonneau A, Fernandes H, Leverger G, Pasquet M, Fouyssac F, et al. Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years. Br J Haematol. 2020 (PUBMED – Site de la revue)
Hadjadj J, Castro CN, Tusseau M, Stolzenberg M-C, Mazerolles F, Aladjidi N, et al. Early-onset autoimmunity associated with SOCS1 haploinsufficiency. Nat Commun 2020 (PUBMED – Site de la revue)
Marxgut M, Adjaoud D, Aladjidi N, Armari C, Marxgut L, Rubio A. Generalized Verrucosis Revealing a Life-Threatening and Unlabeled T-Cell Lymphopenia Associated With Autoimmune Hemolytic Anemia: A Case Report and Review of Literature. J Pediatr Hematol Oncol. 2020 (PUBMED – Site de la revue)
2019
Pincez T, Neven B, Le Pointe HD, Varlet P, Fernandes H, Gareton A et al., Neurological Involvement in Childhood Evans Syndrome. J Clin Immunol 2019 (PUBMED – Site de la revue)
Hadjadj J, Aladjidi N, Fernandes H, Leverger G, Magérus-Chatinet A, Mazerolles F et al., Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood 2019 (PUBMED – Site de la revue)
2018
Besnard C, Levy E, Aladjidi N, Stolzenberg MC, Magerus-Chatinet A, Alibeu O, et al. Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations. Clinical immunology. 2018. (PUBMED – Site de la revue)
Penel Page M, Bertrand Y, Fernandes H, Kherfellah D, Leverger G, Leblanc T et al. Treatment with cyclosporin in auto-immune cytopenias in children: The experience from the French cohort OBS’CEREVANCE Am J Hematol 2018 (PUBMED – Site de la revue)
2017
Roche O, Aladjidi N, Rakotonjanahary J, Leverger G, Leblanc T, Thomas C, et al. Evaluation of the efficiency of hydroxychloroquine in treating children with immune thrombocytopenia (ITP). American journal of hematology. 2017.(PUBMED – Site de la revue)
Ducassou S, Leverger G, Fernandes H, Chambost H, Bertrand Y, Armari-Alla C, et al. Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study Br J Haematol. 2017.(PUBMED – Site de la revue)
Aladjidi N, Jutand M-A, Beaubois C, Fernandes H, Jeanpetit J, Coureau G, et al. Reliable assessment of the incidence of childhood autoimmune hemolytic anemia. Pediatric Blood Cancer. 2017 Jul 27. (PUBMED – Site de la revue)
2016
Grimaldi-Bensouda L, Nordon C, Leblanc T, Abenhaim L, Allali S, Armari-Alla C, et al. Childhood immune thrombocytopenia: A nationwide cohort study on condition management and outcomes. Pediatric blood & cancer. 2016.(PUBMED – Site de la revue)
2015
Aladjidi N, Fernandes H, Leblanc T, Vareliette A, Rieux-Laucat F, Bertrand Y, et al. Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort. Frontiers in pediatrics. 2015.(PUBMED – Site de la revue)
Pasquet M, Aladjidi N, Guitton C, Leblanc T, Perel Y, G. L. Recommandations d’utilisation des agonistes du récepteur de la thrombopoïétine dans le purpura thrombopénique immunologique de l’enfant et de l’adolescent. Rev Onc Hematol Pedia. 2015;3(1).(Site de la revue)
2014
Pasquet M, Aladjidi N, Guiton C, Courcoux MF, Munzer M, Auvrignon A, et al. Romiplostim in children with chronic immune thrombocytopenia (ITP): the French experience. Br J Haematol. 2014.(PUBMED – Site de la revue)
2012
Aladjidi N, Santiago R, Pondarre C, Lambilliotte A, Leverger G, Godard Sebillotte C, et al. Revisiting Splenectomy in Childhood Immune Thrombocytopenic Purpura in the Era of New Therapies: The French Experience. J Blood Disord Transfus. 2012;S3:003.(Site de la revue)
2011
Aladjidi N, Leverger G, Leblanc T, Picat MQ, Michel G, Bertrand Y, et al. New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica. 2011;96(5):655-63.(PUBMED – Site de la revue)
Fresneau B, Petit A, Courcoux MF, Tabone MD, Auvrignon A, Landman-Parker J, et al. Vinblastine in the treatment of children and adolescents with refractory immune thrombocytopenia. American journal of hematology. 2011;86(9):785-7.(PUBMED – Site de la revue)